ADVERTISEMENT

ELKH Researchers Win U.S. Grant for Cariprazine Project

Pharma

Researchers of the Eötvös Loránd Research Network (ELKH) have won a USD 413,000 grant from the United States National Institutes of Health (NIH) to study the mechanism of action of the Hungarian-developed antipsychotic cariprazine, according to a report by state news wire MTI.

The project could open new avenues in the research of psychiatric disease based on neurobiology, ELKH said.

ELKH consultant István Katona is partnering on the two-year project with ELKH research professor György Miklós Keserű. The two researchers recently started a review of cariprazine and published their first results in the journal Nature Communications.

Hungary Motor Fuel Prices Below Regional Average Energy Trade

Hungary Motor Fuel Prices Below Regional Average

EC Advances Infringement Procedure Over Hungary's Sovereignt... EU

EC Advances Infringement Procedure Over Hungary's Sovereignt...

Hell Energy Inaugurates HUF 80 bln Capacity Expansion Manufacturing

Hell Energy Inaugurates HUF 80 bln Capacity Expansion

Puskás Arena to Host 2026 Champions League Final In Budapest

Puskás Arena to Host 2026 Champions League Final

SUPPORT THE BUDAPEST BUSINESS JOURNAL

Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.